Publications by authors named "Attanasio A"

Background: For the time being, tafamidis is the only approved treatment for wild-type transthyretin cardiac amyloidosis. However, benefits on all-cause death only emerge after ≈18 months. The current available staging systems are unable to specifically discriminate patients at high risk of death within 18 months from diagnosis, and the selection of patients who are expected to benefit from tafamidis is left to the clinical judgment of treating physicians, being often based primarily (and sometimes only) on age.

View Article and Find Full Text PDF

Background: Cardiovascular magnetic resonance (CMR) is the gold-standard to estimate right ventricular (RV) volumes, which are key for clinical management of patients with repaired tetralogy of Fallot (rTOF). Semi-automated threshold-based methods (SAT) have been proposed for CMR post-processing as alternatives to fully manual standard tracing. We investigated the impact of SAT on RV analysis using different thresholds in rTOF patients.

View Article and Find Full Text PDF
Article Synopsis
  • The HF syndrome involves an imbalance in the autonomic nervous system, leading to an increase in sympathetic activity and various cardiac changes that result in chronotropic incompetence (CI), or the inability to raise heart rate with activity.
  • CI is linked to decreased exercise capacity and poorer health outcomes, and the definition of CI can vary, complicating its assessment.
  • While β-blockers can lower peak heart rate, they improve prognosis in heart failure, and strategies like rate-adapting pacing are being explored to address the reduced heart rate response during exercise.
View Article and Find Full Text PDF
Article Synopsis
  • Fabry Disease cardiomyopathy (FDc) and sarcomeric hypertrophic cardiomyopathy (HCM) show similar hypertrophic heart features, particularly anomalies of the mitral valve apparatus (AMVA), which were assessed in this study for better diagnosis and understanding of disease progression.
  • The study involved 80 Fabry patients and 40 HCM patients, utilizing cardiovascular magnetic resonance (CMR) imaging to measure various AMVA and compare groups with similar levels of left ventricular hypertrophy.
  • Results indicated that Fabry patients exhibited greater hypertrophy of papillary muscles compared to HCM patients, alongside significant anomalies like apical displacement, supporting the idea that AMVA may serve as early indicators in Fabry disease. *
View Article and Find Full Text PDF

cardiomyopathy is a rare genetic disorder that manifests early in life with an autosomal dominant inheritance pattern. It harbors left ventricular hypertrophy (LVH), ventricular pre-excitation and progressively worsening conduction system defects. Its estimated prevalence among patients with LVH ranges from 0.

View Article and Find Full Text PDF

Coherent interconversion between microwave and optical frequencies can serve as both classical and quantum interfaces for computing, communication, and sensing. Here, we present a compact microwave-optical transducer based on monolithic integration of piezoelectric actuators on silicon nitride photonic circuits. Such an actuator couples microwave signals to a high-overtone bulk acoustic resonator defined by the silica cladding of the optical waveguide core, suspended to enhance electromechanical and optomechanical couplings.

View Article and Find Full Text PDF

Background: Early identification of immunoglobulin light-chain amyloidosis (AL) is crucial due to its rapid progression. Monoclonal light-chain (M-LC) testing is the first step in the diagnostic workup for patients with suspected cardiac amyloidosis (CA). We aimed to determine whether the time interval between the first CA suspicion and M-LC testing can be related to AL amyloidosis survival outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Daratumumab-based treatments are considered the new standard therapy for newly diagnosed AL amyloidosis patients, supported by findings from the ANDROMEDA study.
  • A prospective observational study involving 88 newly diagnosed patients explored daratumumab's efficacy and safety, revealing a low rate of serious side effects (16%) and a high overall hematologic response rate of 75%.
  • The study found that daratumumab was effective in advanced cases, with similar rates of hematologic and organ responses between patients with more severe disease stages and those with less severe stages.
View Article and Find Full Text PDF

Micro-machining is a widespread finishing process for fabricating accurate parts as biomedical devices. The continuous effort in reducing the gap between the micro- and macro-domains is connected to the transition from conventional to micro-scale machining. This process generates several undesired issues, which complicate the process's optimization, and tool run-out is one of the most difficult phenomena to experimentally investigate.

View Article and Find Full Text PDF